Threshold Pharmaceuticals, Inc.(NASDAQ : THLD)
THLD PreMarket: $ () as of AM
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Health Technology » Biotechnology
Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It develops its product candidates based on hypoxia-activated prodrug technology: evofosfamide and tarloxotinib bromide. It also seeks to optimize patient selectivity for its hypoxia-targeted therapeutics through the development of its [18F]-HX4 investigational hypoxia Positron Emission Tomography tracer. The company was founded by George Francis Tidmarsh and Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, C